F
Fangjing Shi
Publications - 1
Citations - 3
Fangjing Shi is an academic researcher. The author has contributed to research in topics: Lower risk & Decitabine. The author has an hindex of 1, co-authored 1 publications receiving 2 citations.
Papers
More filters
Journal ArticleDOI
Decitabine for myelodysplastic syndromes: dose comparison in a real world clinical setting.
Yanling Ren,Huifang Jiang,Fangjing Shi,Li Ye,Yingwan Luo,Xinping Zhou,Chen Mei,Liya Ma,Weilai Xu,Peipei Lin,Chao Hu,Jie Jin,Hongyan Tong +12 more
TL;DR: 15 mg/m2/d decitabine is associated with a lower incidence of hematological toxicities and longer OS and may be more suitable for patients with relatively lower risk.